End-stage Liver Disease in Children

Area of Science:

• Pediatric Gastroenterology and Hepatology
• Critical Care Medicine
• Transplant Surgery

Background:

• End-stage liver disease (ESLD) in children presents complex challenges requiring multidisciplinary management.
• Caregiver involvement is crucial for implementing treatment plans tailored to a child's developmental stage.

Purpose of the Study:

• To outline comprehensive management strategies for pediatric ESLD.
• To detail approaches for nutritional deficiencies, ascites, pruritus, encephalopathy, and portal hypertension.

Main Methods:

• Routine monitoring and supplementation of fat-soluble vitamins (A, D, E, K) and micronutrients.
• Pharmacological interventions including spironolactone, diuretics, ursodeoxycholic acid, rifampin, lactulose, and protein restriction.
• Procedural interventions such as paracentesis, endoscopic variceal banding/sclerotherapy, surgical shunting, and orthotopic liver transplantation.

Main Results:

• Nutritional support and vitamin/micronutrient supplementation are vital for growth.
• Ascites and pruritus often respond to medical management, with procedural interventions reserved for refractory cases.
• Hepatic encephalopathy management involves monitoring serum ammonia and implementing dietary changes and lactulose.

Conclusions:

• Effective management of pediatric ESLD necessitates a coordinated approach addressing multiple complications.
• Liver transplantation remains a definitive option for children with end-stage liver disease unresponsive to other treatments.